Drug Database
Back to search

Ireland· IE-PA-EU/1/20/1528/037-038

COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year

A covid-19, rna-based vaccine product containing covid-19 mrna vaccine (nucleoside-modified), registered in Ireland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedCOMIRNATY KP.2 30 micrograms/dose dis…ATCJ07BN01REGISTER NO.IE-PA-EU/1/20/1528/03…PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about covid-19 mrna vaccine (nucleoside-modified)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose
Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
COVID-19 mRNA vaccine (nucleoside-modified)
Manufacturer
BioNTech Manufacturing GmbH
Country
Ireland (IE)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/20/1528/037-038

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8d933cb-beff-44c5-a51b-146fdefccd48
GET /v1/drugs/a8d933cb-beff-44c5-a51b-146fdefccd48?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersion for injection",
  "routes": null,
  "source": "hpra",
  "atc_all": [
    "J07BN01"
  ],
  "strength": null,
  "pa_number": "EU/1/20/1528/037-038",
  "substances": [
    "COVID-19 mRNA vaccine (nucleoside-modified)"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "21/12/2020",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console